MustGrow Receives Final Approval to List on the TSX Venture Exchange

2022-11-10

Saskatoon, Saskatchewan--(News - November 9, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce that the TSX Venture Exchange ("TSXV") has approved the Company's application to list its common shares (the "Shares") on the TSXV. The Shares will commence trading on the TSXV under the ticker symbol "MGRO" at the opening of the Market on November 11, 2022. Shareholders will not be required to take any action in connection with MustGrow's listing on the TSXV. The Shares will also continue to be listed on the OTCQB Marketplace in the United States under the symbol "MGROF" and on the Frankfurt Stock Exchange under the symbol "0C0". In connection with the listing of the Shares on the TSXV, the Company has submitted a request to voluntarily delist the Shares from the Canadian Securities Exchange ("CSE"). The last day of trading of the Company's shares on the CSE will be November 10, 2022. For further details, please refer to the Listing Application on the Company's SEDAR pro at . --------- About MustGrow MustGrow is an agriculture biotech company developing organic biopesticides and bioherbicides by harnessing the natural defense mechanism of the mustard plant to protect the global food supply from diseases, insect pests, and weeds. MustGrow and its leading global partners - Janssen PMP (pharmaceutical division of Johnson & Johnson), Bayer, Sumitomo Corporation, and Univar Solutions' NexusBioAg - are developing mustard-based organic solutions to potentially replace harmful synthetic chemicals. Over 150 independent tests have been completed, validating MustGrow's safe and effective approach to crop and food protection. Pending regulatory approval, MustGrow's patented liquid products could be applied through injection, standard drip, or spray equipment, improving functionality and performance features. Now a platform technology, MustGrow and its global partners are pursuing applications in several different industries from preplant soil treatment and weed control, to postharvest disease control and food preservation. MustGrow has approximately 49.7 million basic common shares issued and outstanding and 55.6 million shares fully diluted. For further details, please visit . ON BEHALF OF THE BOARD "Corey Giasson" Director & CEO Phone: +1-306-668-2652 info@mustgrow.ca MustGrow Forward-Looking Statements Certain statements included in this news release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Examples of forward-looking statements in this news release include statements MustGrow makes regarding the anticipated date of the commencement of trading of the Company's Shares on the TSXV. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) the preferences and choices of agricultural regulators with respect to product approval timelines; (ii) the ability of MustGrow's partners to meet obligations under their respective agreements; and (iii) other risks described in more detail in MustGrow's Annual Information Form for the year ended December 31, 2021 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available at . Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States. Neither the CSE, the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the CSE and TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release. © 2022 MustGrow Biologics Corp. All rights reserved. To view the source version of this press release, please visit